Mitochondria-targeting biocompatible fluorescent BODIPY probes

Edward R. H. Walter,Lawrence Cho-Cheung Lee,Peter Kam-Keung Leung,Kenneth Kam-Wing Lo,Nicholas J Long
DOI: https://doi.org/10.1039/d3sc06445j
IF: 8.4
2024-02-22
Chemical Science
Abstract:An increase in the mitochondrial membrane potential (MMP) is a characteristic feature of cancer and cardiovascular disease. Therefore, it remains of crucial importance to develop new and improved fluorescent probes that are sensitive to the MMP, to report on mitochondrial health and function. Reported here are the design, synthesis, photophysical and biological characterisation of a series of BODIPY dyes, BODIPY-Mito-n, for mitochondria-targeted fluorescence imaging applications. Six BODIPY-Mito-n analogues were synthesised under mild conditions, and displayed excellent fluorescence quantum yields of between 0.59 and 0.72 in aqueous environments at physiological pH (pH = 7.4). The incorporation of poly(ethylene glycol) (PEG) chains to the triarylphosphonium cation moiety significantly improved the biocompatability of the probes (BODIPY-Mito-6, IC50 > 50 μM). All BODIPY-Mito-n compounds demonstrated a high MMP-sensitive localisation in the mitochondria, with Pearson's correlation coefficients (PCC) of between 0.76 and 0.96. Compounds BODIPY-Mito-2 and BODIPY-Mito-6 revealed the highest sensitivity to the MMP, with a decrease in the fluorescence intensity of 62 % and 75 % respectively following MMP depolarisation. It is anticipated that the highest MMP sensitivity and enhanced biocompatability of BODIPY-Mito-6 could lead to the development of new probes for mitochondrial imaging in the future.
chemistry, multidisciplinary
What problem does this paper attempt to address?
The problem this paper attempts to address is the development of new and improved fluorescent probes that are sensitive to mitochondrial membrane potential (MMP) for reporting mitochondrial health and function. Specifically, the study aims to design, synthesize, and characterize a series of BODIPY dyes (BODIPY-Mito-n) that possess good biocompatibility and high MMP sensitivity, suitable for mitochondrial-targeted fluorescence imaging applications. ### Background Mitochondria are important subcellular organelles responsible primarily for generating ATP through oxidative phosphorylation. Since the discovery of this function in 1957, the role of mitochondria has been considered more complex, with mitochondrial function and dysfunction now recognized as significant factors in cancer cell metabolism, neurodegenerative diseases, and aging. Mitochondria have a negative membrane potential (MMP), which allows lipophilic cations to progressively accumulate in the mitochondrial matrix. Connecting lipophilic cations (such as triphenylphosphine) to small molecules can increase their accumulation in the extracellular space by 1000 times. ### Problem In cancer and cardiovascular diseases, MMP increases significantly. Therefore, developing compounds that can accumulate in an MMP-dependent manner is crucial for non-invasive imaging of mitochondrial function and delivering therapeutic cargo. However, a major current issue is developing new and improved fluorescent probes that can accumulate and be retained in an MMP-dependent manner. Historically, the accumulation and retention of BODIPY-based compounds have either been independent of MMP or have not been experimentally determined for this sensitivity, limiting the application of these probes in reporting mitochondrial function. ### Objectives The study aims to design, synthesize, and characterize a series of BODIPY-Mito-n compounds with the following characteristics: 1. **High fluorescence quantum yield**: Exhibiting excellent fluorescence quantum yield under physiological pH conditions. 2. **High MMP sensitivity**: Highly sensitive to changes in MMP, thereby reflecting the functional state of mitochondria. 3. **Good biocompatibility**: Improved biocompatibility through modifications such as the introduction of polyethylene glycol (PEG) chains. ### Results The research team synthesized six BODIPY-Mito-n analogs and conducted detailed photophysical and biological characterizations. The results showed that these compounds exhibited excellent fluorescence quantum yields (0.59-0.72) under physiological pH conditions and were highly sensitive to MMP. Specifically, BODIPY-Mito-2 and BODIPY-Mito-6 showed a decrease in fluorescence intensity by 62% and 75%, respectively, after MMP depolarization, indicating the highest MMP sensitivity. Additionally, the introduction of PEG chains significantly improved the biocompatibility of the compounds, with BODIPY-Mito-6 having an IC50 value greater than 50 mM. ### Conclusion The study successfully developed a series of BODIPY-Mito-n compounds with high MMP sensitivity and good biocompatibility, which hold promise for future mitochondrial imaging applications, particularly in the diagnosis and monitoring of cancer and cardiovascular diseases.